Is photodynamic therapy a solution for keloid?

Giornale Italiano di Dermatologia e Venereologia

Volumn 146, Issue 6, 2011, Pages 463-472

  Nie, Z ^a  

^a SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Keloid; Photochemotherapy; Skin disease

Indexed keywords

ALBINTERFERON ALPHA2B; ALPHA INTERFERON; AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; BETA INTERFERON; COLLAGEN; DECORIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; LYMPHOTOXIN; MELANIN; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN BINDING PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; CELL DEATH; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CROSS LINKING; CYTOKINE PRODUCTION; DRUG MECHANISM; ETHNICITY; EXTRACELLULAR MATRIX; FIBROBLAST; FOLLOW UP; HYPERTROPHIC SCAR; IN VITRO STUDY; INCIDENCE; KELOID; KERATINOCYTE; LIGHT ABSORPTION; MORPHEA; PARACRINE SIGNALING; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; PUVA; REVIEW; SCLERODERMA; SKIN ABSORPTION; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME; WOUND HEALING IMPAIRMENT;

EID: 84856934170     PISSN: 03920488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Morton CA, McKenna KE and Rhodes LE: Guidelines for topical photodynamic therapy: update. Br J Dermatol 2008;159:1245-66.
2. Karrer S, Abels C, Landthaler M, Szeimies RM. Topical photodynamic therapy for localized scleroderma. Acta Derm Venerol 2000;80:26-7. (Pubitemid 30110844)
3. Karrer S, Bosserhoff AK, Weiderer P, Landthaler M, Szeimies RM. Influence of 5-aminolevulinic acid and red light on collagen metabolism of human dermal fibroblasts. J Invest Dermatol 2003;120:325-31. (Pubitemid 36513085)
4. Wolfram D, Tzankov A, Pulzl P, Piza-Katzere H. Hypertrophic scars and keloids:a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg 2009;35:171-81.
5. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG. Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 2011;17:113-25.
6. Nie Z, Bayat A, Behzad F, Rhodes LE. Positive response of a recurrent keloid scar to topical methy aminolevulinate-photodynamic therapy. Photodermatol Photoimmunol Photomed 2010;26:330-2.
7. Karrer S, Bosserhoff AK, Weiderer P, Landthaler M, Szeimies RM. Keratinocyte-derived cytokines after photodynamic therapy and their paracrine induction of matrix metalloproteinases in fibroblasts. Bri J Dermatol 2004;151:776-83. (Pubitemid 39482110)
8. Verrico AK, Moor JV. Expression of the collagen-related heat shock protein HSP47 in fibroblasts treated with hyperthermia or photodynamic therapy. Bri J Cancer 1997;76:719-24. (Pubitemid 27379737)
9. Waterman PR, Overhaus M, Hechenkamp J, Nigri GR, Fungaloi PFC, Landis ME et al. Mechanisms of reduced human vascular cell migration after photodynamic therapy. Photochem Photobiol 2002;75:46-50.
10. Cai H, Gu Y, Sun Q, Zeng J, Dong N, Zhao G. Effect of hematoporphyrin monomethyl ether-mediated photodynamic therapy on hypertrophic scar fibroblasts. Photodermatol Photoimmunol Photomed 2011;27:90-6.
11. Friedman DW, Boyd CD, Mackenzie JW, Norton P, Olsoon RM and Deak SB:Regulation of collagen gene expression in keloids and hypertrophic scars. J Surg Res 1993;55:214-22. (Pubitemid 23335800)
12. Shih B, Garside E, McGrouther DA, and Bayat A:Molecular dissection of abnormal wound healing processes resulting in keloid disease. Wound Rep Reg 2010;18:139-53.
13. Ethirajan M, Chen YH, Joshi P, Pandey RK:The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chem Soc Rev 2011;40:340-62.
14. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO et al. Photodynamic therapy of cancer: an update. Ca Cancer J Clin 2011;1:1-32.
15. st edition, edited by Ferguson J and Dover JS; 2006.
16. Linuma S, Farshi SS, Ortel B, Hasan T. A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. Br J Cancer 1994;70:21-8. (Pubitemid 24203623)
17. Issa MC, Piñeiro-Maceira J, Vieira MT, Olej B, Mandarim-de-Lacerda CA, Luiz RR et al. Photorejuvenation with topical methyl aminolevulinate and red light: a randomized, prospective, clinical, histopathologic, and morphometric study. Dermatol Surg 2010;36:39-48.
18. Axer-siegel R, Rhrlich R, Yassur Y, Rosenblatt I, Kramer M, Priel E et al. Photodynamic therapy for age-related macular degeneration in a clinical setting: visual results and angiographic patterns. Am J Ophthalmol 2004;137:258-64. (Pubitemid 38220997)
19. Lin HP, Chen HM, Yu CH, Yang H, Wang YP, Chiang CP. Topical photodynamic therapy is very effective for oral verrucous hyperplasia and oral erythroleukoplakia. J Oral Pathol Med 2010;39:624-30.
20. Soergel P, Loehr-Schulz R, Hillemanns M, Landwehr S, Makowski L, Hillemanns P. Effects of photodynamic therapy using topical applied hexylaminolevulinate and methylaminolevulinate upon the integrity of cervical epithelium. Lasers Surgery Med 2010;42:624-30.
21. Loh CS, MacRobert AJ, Buonaccorsi G, Krasner N, Bown SG. Mucosal ablation using photodynamic therapy for the treatment of dysplasia: an experimental study in the normal rat stomach. Gut 1996;38:71-8. (Pubitemid 26022523)
22. Shackley DC, Haylett A, Whitehurst C, Betts CD, O'Flynn K, Clarke NW et al. Comparison of the cellular molecular stress responses after treatments used in bladder cancer. BJU International 2002;90:924-32. (Pubitemid 36693631)
23. Mansfielda R, Bownb S, McEwana J. Photodynamic therapy: shedding light on restenosis. Heart 2001;86:612-8.
24. Tosa M, Murakami M, Iwakiri I, Umezawa H and Hyakusoku H. Treatment of keloids with photodynamic therapy using 5-aminolevulinic acid (5-ALA-PDT):a preliminary study. The second Japan scar workshop 2007.
25. Campbell SM, Tyrrell J, Marshall R, Curnow A. Effect of MAL-photodynamic therapy on hypertrophic scarring. Photodiagnosis Photodyn Ther 2010;7:183-8.
26. Chiu LL, Sun CH, Yeh AT, Torkian B, Karamzadeh A, Tromberg B et al. Photodynamic therapy on keloid fibroblasts in tissue-engineered keratinocyte-fibroblast co-culture. Lasers Surg Med 2005;37:231-44. (Pubitemid 41464825)
27. Sayah D, Soo C, Shaw WW, Watson J, Messadi D, Longaker MT et al. Downregulation of apoptosis-related genes in keloid tissues. J Surg Res 1999;87:209-16. (Pubitemid 30000588)
28. McCauley RL, Chopra V, Li YY, Herndon DN, Robson MC. Altered cytokine production in black patients with keloids. J Clin Immunol 1992;12:300-8.
29. Lee JP, Jalili RB, Tredger EE, Demare JR, Ghahary A. Antifibrogenic effects of liposome-encapsulated IFN-alpha2b cream on skin wounds in a fibrotic rabbit ear model. J Interferon cytokine Res 2005;25:627-31. (Pubitemid 41507818)
30. Larrabee EF, East CA, Jaffe HS, Stephenson C, Peterson KE. Intralesional interferon gamma treatment for keloids and hypertrophic scars. Arch Otolaryngol Head Neck Surg 1990;116:1159-62. (Pubitemid 20328956)
31. Postlethwaite AE, Lachman LB, Mainardi GL, Kang AH. Interleukin 1 stimulation of collagenase production by cultured fibroblasts. J Exp Med 1983;157:801-6. (Pubitemid 13145078)
32. Ghazizadeh M, Tosa M, Shimizu H, Hyakusoku H, Kawanami O. Functional implications of the IL-6 signalling pathway in keloid pathogenesis. J Invest Dermatol 2007;127:98-105. (Pubitemid 46005666)
33. Lim JI, Phan TT, Song C, Tan WT, Longaker MT. Investigation of the influence of keloid-derived keratinocytes on fibroblast growth and proliferation in vitro. Plast Reconstr Surg 2001;107:797-808. (Pubitemid 32180128)
34. Ansel J, Perry P, Brown K, Damm D, Phan T, Hart C et al. Cytokine modulation of keratinocytes cytokines. J Invest Dermatol 1990;94:S101-107.
35. Kondo S, Kooshesh F, Sauder DN. Penetration of keratinocyte-derived cytokines into basement membrane. J cell Physiol 1997;171:190-5. (Pubitemid 27205060)
36. Evangelou G, Farrar MD, White RD, Sorefan NB, Wright KP, McLean K et al. Topical ALA-PDT produces an inflammatory infiltrate but reduces Langerhans cells in healthy human skin in vivo. Br J Dermatol 2011;165:513-9.
37. Han YP, Tuan TL, Wu HY, Hughes M, Garner WL. TNF-α stimulates activation of pro-MMP2 in human skin through NF-κB mediated induction of MT1-MMP. J Cell Science 2000;114:131-9. (Pubitemid 32118063)
38. Bock O, Yu H, Zitron S, Bayat A, Ferguson MW, Mrowietz U. Studies of transforming growth factors beta 1-3 and their receptors I and II in fibroblast or keloids and hypertrophic scars. Acta Derm Venerol 2005;85:216-20. (Pubitemid 40695163)
39. Byun JY, Lee GY, Choi HY, Myung KB, Choi YW. The expression of TGF-β1 and IL-10 in cultured fibroblasts after ALA-IPL photodynamic treatment. Ann Dermatol 2011;23:19-22.
40. Statius van Eps RG, Adili F, Watkins MT, Anderson RR, LaMuraglia GM. Photodynamic therapy of extracellular matrix stimulates endothelial cell growth by inactivation of matrix-associated transforming growth factor-beta. Lab Invest 1997;76:257-66. (Pubitemid 27082069)
41. Statius van Eps RG, Mark LL, Schierech J, LaMuraglia GM. Photodynamic therapy inhibits the injury-induced fibrotic response of vascular smooth muscle cells. Eur J Vasc Endovasc Surg 1999;18:417-23.
42. Haisa M, Okochi H and Grotendorst GR. Elevated levels of PDGF alpha receptors in keloid fibroblasts contribute to an enhanced response to PDGF. J Invest Dermatol 1994;103:560-3. (Pubitemid 24314846)
43. Messadi DV, Le A, Berg S, Huang G, Zhuang W, Bertolami CN. Effects of TGF-beta 1 on PDGF receptors expression in human scar fibroblasts. Front Biosci 1998;3:a16-22.
44. Peranteau WH, Zhang L, Muvarak N, Badillo AT, Radu A, Zoltick PW et al. IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. J Invest Dermatol 2008;128:1852-60. (Pubitemid 351847365)
45. Liechty KW, Kim HB, Adzick NS, Crombleholme TM. Foetal wound repair results in scar formation in interleukin 10 - deficient mice in a syngeneic murine model of scarless foetal wound repair. J Pediatr Surg 2000;35:866-72.
46. Gollnick SO, Liu X, Owczarczak B, Musser DA, Henderson BW. Altered expression of interleukin 6 and interleukin 10 as a result of photodynamic therapy in vivo. Cancer Res 1997;57:3904-9. (Pubitemid 27427673)
47. Smith JC, Boone BE, Opalenik SR, Williams SM, Russell SB. Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol 2008;128:1298-310. (Pubitemid 351543197)
48. Tanaka H, Okada T, Konishi H, Tsuji T. The effect of reactive oxygen species on the biosynthesis of collagen and glycosaminoglycans in cultured human dermal fibroblasts. Arch Dermatol Res 1993;285:352-5. (Pubitemid 23265517)
49. Nakai A, Satoh M, Hirayoishi K, Nagata K. Involvement of the stress protein HSP47 in procollagen processing in the endoplasmic reticulum. J Cell Biol 1992;117:903-14.
50. Sunamoto M, Kuze K, Tsuji H, Ohishi N, Yagi K, Kita T et al. Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress collagen accumulation in experimental glomerulonephritis. Lab Invest 1998;78:967-72. (Pubitemid 28378211)
51. Naitoh M, Hosokawa N, Kubota H, Tanaka T, Shirane H, Sawada M et al. Upregulation of hsp47 and collagen type III in the dermal fibrotic disease, keloid. Biochem Biophys Res Commun 2001;280:1316-22. (Pubitemid 32917787)
52. Fantini F, Creco A, Cesinaro AM, Currenti T, Peris K, Vaschieri C et al. Pathologic changes after photodynamic therapy for basal cell carcinoma and Bowen's disease:a histological and immunohistochemical investigation. Arch Dermatol 2008;144:186-94. (Pubitemid 351287001)
53. Park MY, Sohn S, Lee ES, Kim YC. Photorejuvenation induced by 5-aminolevulinic acid photodynamic therapy in patients with actinic keratosis:a histologic analysis. J Am Acad Dermatol 2010;62:85-95.
54. El-Mofty M, Mostafa W, Esmat S, Youssef R, Bousseila M, Nagi N et al. Suggested mechanisms of action of UVA phototherapy in morphea:a molecular study. Photodermatol Photoimmunol Photomed 2004;20:93-100. (Pubitemid 38455739)
55. Herrmann G, Wlaschek M, Bolsen K, Prenzel K, Goerz G, Scharffetter-Kochanek K. Photosensitization of uroporphyrin augments the ultraviolet A-induced synthesis of matrix metalloproteinases in human dermal fibroblasts. J Invest Dermtol 1996;107: 398-403. (Pubitemid 26284350)
56. Takahashi H, Komatsu S, Ibe M, Ishida-Yamamoto A, Nakajima S, Sakata I et al. ATX-S10(na)-PDT shows more potent effect on collagen metabolism of human normal and scleroderma dermal fibroblasts than ALA-PDT. Arch Dermatol Res 2006;298:257-63. (Pubitemid 44484443)
57. Overhaus M, Heckenkamp J, Kossodo S, Leszczynski D, LaMuraglia GM. Photodynamic therapy generates a matrix barrier to invasive vascular cell migration. Circ res 2000;86:334-40. (Pubitemid 30108828)
58. Heckenkamp J, Sleksic M, Gawenda M, Breuer S, Brabender J, Mahdavi A et al. Modulation of human adventitial fibroblast function by photodynamic therapy of collagen matrix. Eur J Vasc Endovasc Surg 2004;28:651-9. (Pubitemid 39462660)
59. Sawada H, Isogai Z, Morita A. Altered decorin expression of systemic sclerosis by UVA1 (340-400nm) phototherapy: immunohistochemical analysis of 3 cases. BMC dermatology 2003;3:1-4.
60. Scott PG, Dodd CM, Tredget EE, Ghahary A, Rahemtulla F. Chemical characterization and quantification of proteoglycans in human post-burn hypertrophic and mature scars. Clin Sci (Lond) 1996;90:417-25. (Pubitemid 26149410)
61. Alhady S, Sivanantharajah K. Keloids in various races:A review of 175 cases. Plast Reconstr Surg 1969;44:564-6.
62. Wachowska M, Muchowicz A, Furczuk M, Gabrysiak M, Winiarska M, Wanczyk M et al. Aminolevulinic acid (ALA) as a prodrug in photodynamic therapy of cancer. Molecules 2011;16:4140-64.